A study led by researchers at Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the ...
Aug 10, 2018
0
0
Universitätsmedizin Berlin researchers have positively influenced the immune response in severe viral and bacterial co-infections using a human lung tissue model. They were able to show that the immune mechanisms triggered ...
Jul 14, 2017
0
0
Since its development, CRISPR technology has been applied a range of scientific inquiries, spanning from the genomic editing of Florida orange crops to Zebrafish. In work recently published in PLOS Pathogens, Robert Jan Lebbink ...
Aug 5, 2016
0
15
With all but two countries worldwide, Pakistan and Afghanistan, declared polio-free, the eradication of the devastating viral disease in the near future is a real possibility. A study published on August 27th in PLOS Pathogens ...
Aug 27, 2015
0
11
Researchers at Dalhousie Medical School have discovered that a gene found in a common herpes virus plays a key role in the development of several AIDS-related cancers – including a form of skin cancer known as Kaposi's ...
May 12, 2015
0
20
Retroviruses are best known for causing contagious scourges such as AIDS, or more sporadically, cancer.
Dec 18, 2014
0
0
Antibodies and their derivatives can protect plants and animals—including humans—against viruses. Members of this class of drugs are usually highly specific against components of a particular virus, and mutations in the ...
Jun 26, 2014
0
0
Often the key to any victory is to fully understand your opponent. This is especially true when that opponent is a significant foodborne bacterial pathogen such as E. coli O157:H7.
Dec 13, 2013
0
0
A blood test developed by researchers at Duke Medicine showed more than 90-percent accuracy in distinguishing between viral and bacterial infections when tested in people with respiratory illnesses.
Sep 18, 2013
0
0
In collaboration with colleagues in Rotterdam, an LMU research team led by Professor Gerd Sutter has produced the first candidate vaccine against the MERS virus, a novel and highly pathogenic coronavirus.
Sep 6, 2013
0
0
